Sidley saved our company from hostility. Former employee

New Post Public Reply Private Reply Replies (0) Message Board
Firelife619
1,017
Sidley saved our company from hostility. Former employee assigning Amarex; the false Prostate test from Pastell. Dr. Pattentson trying to patent the obvious. A proxy vote that was planned before it was made public: (Reddit moderator superChet being Beaty is proof.)
Ambulance chasers, sudden Ivermectin hype with false data to take away from Philippines hype. (Which btw is now being linked to Liver failure). HELLO NASH!

Manipulators: Failed patent hijacking. Failed proxy vote, failed appeal. Not allowing an audit to now potentially ruining NSFs reputation. Their lives are a failure and will be.

We are facing: Dark money. Manipulators selling and buying less than 1% of the total volume. Shorting. Even synthetic shares to bring down the SP.

When I recently bought a large lump sum on 2 separate occasions, I saw the ASK wall get taken down immediately. And Before the next wall was filled, it didn’t process.

The ask wall was almost torn down, and they kept adding shares to the same ask as my bid suddenly was shown to support the old wall I had just broken down

Why?

Because someone manipulated the price after I brought it up.

So I quickly cancelled the order, then broke down the next ASK and the graph started to spike until they manipulated it again and put another wall. Eventually my order was filled and it was like my buy didn’t do anything.

They do this so our company is FORCED to dilute.

It’s in the companies best interest to fight back and also make sure our drug is used to max potential for the patients.

We have to understand: Some things are said to improve a lawyers position in court, some things are said for investors to relax.

The 10Q:

“The Company believes that material uncertainties related to the ultimate regulatory approval of leronlimab for commercial sale have been significantly reduced”

This tells us that something big is possible. That’s for investors.

I know some are upset about the SP and don’t want to be told by Nader to chill. But honestly, he’s right. He only gets all the blame and anger bc of the manipulation.

We aren’t able to enjoy knowing we saved lives.
Possible patients like myself aren’t able to enjoy a Long Hauler free life.
Investors aren’t able to enjoy their investment.

But in reality, we have a molecule that can change the world with a domino of indications ready to fall in place.

Break down:

“In order to obtain the bond, the Company will be required to tender $6.5 million in cash as collateral to the surety issuing the bond. IF NECESSARY, the Company will seek an extension of the deadline for posting the bond."

This is what we know:

Nader does NOT like dilution.

No where in this statement does it say they can’t come up with the money.

It’s read as if necessary we can push back the date. That’s it.

The manipulators are controlling the narrative by making you think we can’t come up with the money.

So, WHY dilute the company if the company feels regulatory APPROVAL has been significantly reduced?

We may just be simply pushing the date back to let whatever is pending or will be pending materialize.

We may be experiencing the up part of it soon.

Here’s why:

We owe Samsung ex amount of money.

They wrote it so it can be read as the Samsung relationship isn’t strained. In fact, it’s a STRONG relationship. The words “commercially reasonable efforts” can be interpreted many ways:

Is it “as long as you guys submit your paperwork for commercial usage, we are good on the contract if you primarily keep dealing with us.”

Is it: “just get caught up on the December payment and then we can wing your January payment until Feb. etc”

Is it: “we want to work with you and as long as you show us you care about our relationship, and make reasonable commercial progress, we might even partner up with you.”

The bears are LOUDER. Creatures in the wild get loud when they’re scared. Its no longer repetition to manipulate its LOUD SCREAMS TO GET US OUT ASAP.

It’s a perfect set up for a short squeeze that will start that rollercoaster and they know it. They will just claim longs are paid or outright dumb.

But this Samsung situation strengthens our position in court. We had our backs against the wall, and not paying Samsung on time is proof, your honor.

Say we get a regulatory approval and this lawsuit is pending the way it is. Now we don’t have our backs against the wall and NSF wouldn’t be off the hook for a botched 3 to 1 age stratification issue, or incorrect dates that changed a trials outcome in statistical significance. Or Amarex for negligence of the BLA. + Whatever damages they may have done.

THIS IS WHY Nader sent the email to hurry up and get the BLA submitted. For proof of negligence. An audit isn’t even needed for that, it’s just needed to see HOW MUCH damage they did.

Don’t underestimate SIDLEY. They have things in the bag before it even starts.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

SMART Modular Technologies Advances with CXL Compliance Achievements

Updated Category News Views 246

SMART Modular Technologies Achieves CXL Compliance In a significant development for the tech industry, SMART Modular Technologies, a well-respected name in integrated memory solutions, has successfully earned recognition on the CXL (Compute Express Link) Consortium’s Integrators' List. This announcement signifies their commitment to delivering high-quality memory...

Continue Reading
Navigating Legal Challenges: KinderCare Learning Companies Case

Updated Category News Views 201

Understanding the Legal Landscape for KinderCare Learning Companies In the evolving world of corporate governance, it is crucial for investors to stay informed, particularly regarding legal developments that may affect their interests. KinderCare Learning Companies has recently found itself at the center of a securities class action lawsuit, bringing attention to...

Continue Reading
ASP Isotopes Secures Overwhelming Approval for Renergen Deal

Updated Category News Views 198

ASP Isotopes Sees Major Support for Renergen Acquisition At a pivotal shareholders meeting, ASP Isotopes Inc. (NASDAQ: ASPI), an advanced materials company, announced that Renergen Limited's shareholders overwhelmingly approved its acquisition. The vote, which took place during a recent meeting, revealed that 99.80% of the shareholders in favor of the scheme, showcasing...

Continue Reading
ORR Protection Expands Fire Safety Solutions with DSI Deal

Updated Category News Views 198

ORR Protection Strengthens Its Fire Safety Solutions In a significant move to enhance its fire protection services, ORR Protection Systems, Inc. has acquired Detection & Suppression International (DSI). This strategic acquisition expands ORR Protection's capabilities and reinforces its position as a leader in the fire safety industry. About the Acquisition Located in...

Continue Reading
Analysis of Pennsylvania Housing Market Trends as Winter Arrives

Updated Category News Views 176

Understanding the Pennsylvania Housing Market's December Trends The Pennsylvania housing market exhibited a noticeable cooling trend in December, reflecting seasonal changes and economic patterns. The median sales price for homes fell approximately 5%, recorded at $289,000 in December, a decline from the $305,000 reported in November. Price Trends Compared to Previous...

Continue Reading